Discovering Opportunities: Duran Dogan Basim ve Ambalaj Sanayi And 2 Other Middle Eastern Penny Stocks
As most Gulf markets rise, with Dubai's main index reaching a 17-year high, the Middle East continues to capture investor attention with its robust economic indicators and steady oil prices. Though the term 'penny stocks' might feel like a relic of past market eras, the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.
Name
Share Price
Market Cap
Financial Health Rating
Terminal X Online (TASE:TRX)
₪4.37
₪555.01M
★★★★★★
Menara Ventures Xl - Limited Partnership (TASE:MNRA)
₪2.719
₪12.49M
★★★★★★
Thob Al Aseel (SASE:4012)
SAR4.02
SAR1.6B
★★★★★★
Alarum Technologies (TASE:ALAR)
₪2.811
₪197.21M
★★★★★★
E7 Group PJSC (ADX:E7)
AED1.14
AED2.26B
★★★★★★
Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR)
TRY1.79
TRY1.93B
★★★★★☆
Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR)
AED3.13
AED361.51M
★★★★★★
Dubai Investments PJSC (DFM:DIC)
AED2.41
AED10.25B
★★★★☆☆
Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)
AED0.726
AED441.59M
★★★★★★
Tgi Infrastructures (TASE:TGI)
₪2.335
₪173.59M
★★★★★★
Click here to see the full list of 94 stocks from our Middle Eastern Penny Stocks screener.
We're going to check out a few of the best picks from our screener tool.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Duran Dogan Basim ve Ambalaj Sanayi A.S., along with its subsidiaries, offers packaging products across Turkey and various international markets including Europe, the United States, the Middle East, Africa, and the Asia Pacific; it has a market cap of TRY1.59 billion.
Operations: The company's revenue is primarily generated from its Packaging & Containers segment, amounting to TRY1.90 billion.
Market Cap: TRY1.58B
Duran Dogan Basim ve Ambalaj Sanayi A.S. has shown a reduction in debt levels, with its debt to equity ratio decreasing significantly over the past five years. Despite being unprofitable, the company has managed to reduce its losses annually by 13.4%. Its short-term assets comfortably cover both short and long-term liabilities, indicating a strong liquidity position. However, high net debt to equity remains a concern. Recent earnings reports highlight declining sales and continued net losses, although these losses have narrowed slightly compared to previous periods. The company's dividend is not well covered by earnings, suggesting potential sustainability issues.
Dive into the specifics of Duran Dogan Basim ve Ambalaj Sanayi here with our thorough balance sheet health report.
Explore historical data to track Duran Dogan Basim ve Ambalaj Sanayi's performance over time in our past results report.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Matricelf Ltd is a biotechnology company focused on developing a platform for autologous tissue engineering to address various medical conditions, with a market cap of ₪44.55 million.
Operations: Matricelf Ltd does not currently report any revenue segments.
Market Cap: ₪44.55M
Matricelf Ltd, a pre-revenue biotechnology company with a market cap of ₪44.55 million, recently announced a collaboration with Cellino to advance personalized spinal cord injury treatments. This partnership leverages Cellino's Nebula™ technology and Matricelf's regenerative approach to create scalable therapies. Despite being debt-free and having short-term assets exceeding liabilities, Matricelf faces challenges due to its unprofitability and limited cash runway of less than a year. The management team is experienced, but the board is relatively new. An IND application is planned for next year, aiming to initiate clinical trials for their innovative therapy.
Navigate through the intricacies of Matricelf with our comprehensive balance sheet health report here.
Gain insights into Matricelf's past trends and performance with our report on the company's historical track record.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Ratio Petroleum Energy - Limited Partnership is involved in the exploration, development, and production of oil and gas, with a market cap of ₪62.95 million.
Operations: Ratio Petroleum Energy - Limited Partnership has not reported any revenue segments.
Market Cap: ₪62.95M
Ratio Petroleum Energy - Limited Partnership, with a market cap of ₪62.95 million, is pre-revenue and faces challenges due to its unprofitability and negative return on equity. The company reported a net loss of US$4.18 million for 2024, an improvement from the previous year's larger losses. Despite having no debt and short-term assets exceeding liabilities, its cash runway is limited to less than a year if growth continues at historical rates. The board's average tenure suggests experience; however, the management's experience remains unclear. Share price volatility has decreased but remains high compared to other Israeli stocks.
Click here to discover the nuances of Ratio Petroleum Energy - Limited Partnership with our detailed analytical financial health report.
Review our historical performance report to gain insights into Ratio Petroleum Energy - Limited Partnership's track record.
Embark on your investment journey to our 94 Middle Eastern Penny Stocks selection here.
Searching for a Fresh Perspective? Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include IBSE:DURDO TASE:MTLF and TASE:RTPT.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
31 minutes ago
- Bloomberg
Alleged Iran Money Laundering Network Hit With US Sanctions
The US imposed sanctions on a network of individuals and companies it accuses of laundering billions of dollars from illegal activities for the Iranian government, as the Trump administration continues its 'maximum pressure' campaign against Tehran. The Treasury Department said the penalties target more than 30 individuals, as well as 16 companies based in Hong Kong and the United Arab Emirates.
Yahoo
an hour ago
- Yahoo
3 Promising TSX Penny Stocks With Market Caps Under CA$300M
As the Canadian market navigates ongoing trade uncertainties, investors are finding opportunities amid the shifting landscape. Penny stocks, while an older term, continue to capture interest as they often represent smaller or newer companies with potential for growth at lower price points. In this article, we explore three such penny stocks on the TSX that offer strong fundamentals and hidden value, presenting intriguing possibilities for those looking beyond the big names. Name Share Price Market Cap Financial Health Rating Westbridge Renewable Energy (TSXV:WEB) CA$0.71 CA$75.86M ★★★★★★ PetroTal (TSX:TAL) CA$0.64 CA$585.62M ★★★★★☆ Orezone Gold (TSX:ORE) CA$1.43 CA$753.84M ★★★★★☆ Fintech Select (TSXV:FTEC) CA$0.03 CA$2.4M ★★★★★★ Findev (TSXV:FDI) CA$0.435 CA$12.75M ★★★★★★ Thor Explorations (TSXV:THX) CA$0.71 CA$478.93M ★★★★★★ NTG Clarity Networks (TSXV:NCI) CA$2.50 CA$108.33M ★★★★★★ Intermap Technologies (TSX:IMP) CA$2.20 CA$130.95M ★★★★★☆ Pulse Seismic (TSX:PSD) CA$2.76 CA$133.99M ★★★★★★ Hemisphere Energy (TSXV:HME) CA$1.79 CA$172.09M ★★★★★★ Click here to see the full list of 876 stocks from our TSX Penny Stocks screener. Here's a peek at a few of the choices from the screener. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Telescope Innovations Corp. is a chemical technology company focused on developing manufacturing processes and tools for the pharmaceutical and chemical industries in the United States and Canada, with a market cap of CA$19.32 million. Operations: The company generates revenue from its Chemicals segment, amounting to CA$4.45 million. Market Cap: CA$19.32M Telescope Innovations Corp., with a market cap of CA$19.32 million, is navigating the penny stock landscape by focusing on innovative chemical technologies for battery materials. Despite being unprofitable, it maintains a positive cash flow and has no debt, offering some financial stability. Recent collaborations, such as with Standard Lithium Ltd., highlight its strategic efforts in developing lithium sulfide using its proprietary DualPure™ process—a promising advancement in solid-state battery technology. However, challenges remain as short-term liabilities exceed assets and revenue growth is modest at CA$2.21 million for the last six months reported. Dive into the specifics of Telescope Innovations here with our thorough balance sheet health report. Gain insights into Telescope Innovations' historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: GoldMining Inc. is a mineral exploration company focused on acquiring, exploring, and developing gold and copper assets in the Americas, with a market cap of CA$207.79 million. Operations: GoldMining Inc. does not report any specific revenue segments. Market Cap: CA$207.79M GoldMining Inc., with a market cap of CA$207.79 million, is pre-revenue and unprofitable, yet it remains debt-free, offering some financial stability. The company has less than a year of cash runway based on current free cash flow trends. Recent developments include the approval to advance its Rea Uranium Project in Alberta's Athabasca Basin, positioning GoldMining to capitalize on rising uranium demand for cleaner energy solutions. Additionally, exploration at its São Jorge Project in Brazil is underway with extensive drilling programs planned. Despite these initiatives, the company faces challenges due to limited revenue generation and increasing losses over recent years. Get an in-depth perspective on GoldMining's performance by reading our balance sheet health report here. Gain insights into GoldMining's outlook and expected performance with our report on the company's earnings estimates. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Emerita Resources Corp., through its subsidiary, focuses on acquiring, exploring, and developing mineral properties in Spain with a market cap of CA$279.97 million. Operations: Emerita Resources Corp. has not reported any revenue segments. Market Cap: CA$279.97M Emerita Resources, with a market cap of CA$279.97 million, is pre-revenue and currently unprofitable, yet it maintains financial stability with more cash than debt and short-term assets exceeding liabilities. The seasoned management team has overseen significant advancements in its Iberian Belt West Project in Spain, including improved metallurgical recovery processes for gold and base metals. Recent updates to the Mineral Resource Estimate highlight potential growth through ongoing drilling campaigns at El Cura deposit. However, the company faces challenges with increasing losses reported in recent earnings results and less than a year of cash runway based on free cash flow trends. Navigate through the intricacies of Emerita Resources with our comprehensive balance sheet health report here. Explore Emerita Resources' analyst forecasts in our growth report. Access the full spectrum of 876 TSX Penny Stocks by clicking on this link. Contemplating Other Strategies? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include CNSX:TELI TSX:GOLD and TSXV:EMO. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Medscape
2 hours ago
- Medscape
Contraceptives for Poorest Countries Stuck in Warehouses After US Aid Cuts
LONDON (Reuters) -Contraceptives that could help prevent millions of unwanted pregnancies in some of the world's poorest countries are stuck in warehouses because of U.S. aid cuts and could be destroyed, two aid industry sources and one former government official said. The stock, held in Belgium and Dubai, includes condoms, contraceptive implants, pills and intrauterine devices, together worth around $11 million, the sources told Reuters. It has been stalled since the Trump administration started cutting foreign aid as part of its 'America First' policy in February, as the U.S. government no longer wants to donate the contraceptives or pay the costs for delivery, they said. The U.S. Agency for International Development (USAID) has instead asked the contractor managing its health supply chain, Chemonics, to try to sell it, two of the sources said. An internal USAID memo, sent in April, said a quantity of contraceptives was being kept in warehouses and they should be "immediately transferred to another entity to prevent waste or additional costs". A senior U.S. State Department official told Reuters no decision had been made about the future of the contraceptives. They did not respond to questions about the reasons why the contraceptives were in storage or the impact of the U.S. aid cuts and delays. A spokesperson for Chemonics said they were unable to comment on USAID's plans, but added that the company is working with clients to deliver life-saving aid globally and would continue to support the U.S. government's global health supply chain priorities. The stock represents just under 20% of the supply of contraceptives bought annually by the U.S. for donation overseas, a former USAID official told Reuters. Selling or donating the contraceptives has been challenging, according to the former USAID official, although talks are ongoing. Another option on the table is destroying it, at a cost of several hundred thousand dollars. As time goes on, shelf-lives will also become an issue, one of the sources said. The sources told Reuters that one of the key delays is a lack of response from the U.S. government about what should be done with the stock. It had been destined largely for vulnerable women in sub-Saharan Africa, including young girls who face higher health risks from early pregnancy as well as those fleeing conflict or who otherwise could not afford or access the contraceptives, the sources added. The condoms also help stop the spread of HIV, the former USAID official said. "We cannot dwell on an issue for too long; when urgency and clarity don't align, we have to move on," said Karen Hong, chief of UNFPA's supply chain. She said the agency is now working on Plan B to help fill critical supply gaps. (Reporting by Jennifer Rigby; Editing by Andrew Heavens)
